Novo Nordisk's savings program may apply to the oral formulation as well
Clinical Evidence on GLP-1 Therapy and Blood Pressure Outcomes The SUSTAIN trials, large randomized controlled studies of semaglutide in type 2 diabetes, documented systolic blood pressure reductions of 35 mmHg compared to placebo, with some participants experiencing drops exceeding 10 mmHg
GLP-1s went from #32 in pharmacy spending to #1 in a single year for one company, and another said they spent half a million dollars and were projected to hit $1.2 million the following year
It also supports recovery from alcohol withdrawal, improves brain circulation after strokes, and alleviates nerve pain
Supplementation is recommended for women with PCOS who may have significantly lower levels of Glutathione due to the condition
doi: 10.1097/WNR.0000000000000674 159